News Column

Story stocks

August 25, 2014




% chg: 35.4%

Day's high/low:


Swiss drug giant Roche Holdings is buying the biotech firm for $74 a share, or $8.3 billion in cash. InterMune makes the idiopathic pulmonary fibrosis drug Esbriet. The news lifted other biotech stocks.

Tim Hortons

Burger King is reportedly considering buying the Canadian doughnut and coffee chain. Burger King would move its headquarters to Canada to take advantage of the lower corporate tax rates.

Regado Biosciences

Safety concerns forced the biotech company to terminate enrollment in late-stage trials of its lead drug, REG1. Regado's second experimental drug, REG2, has the same ingredients as REG1.

For more stories on investments and markets, please see HispanicBusiness' Finance Channel

Source: USA Today

Story Tools Facebook Linkedin Twitter RSS Feed Email Alerts & Newsletters